Link: https://links.sgx.com/1.0.0/corporate-announcements/XQCU7218SV0Y3QKB/2575161b639e82e7888768f05259feeb98a20d25f6b5a9afab41b20bbeddbe74

Summary:

• Revenue increased 13.4% to S$77.1 million for FY2025, driven by significant growth in managed healthcare solutions (+21.1%) and mobile & digital health services (+26.1%), as well as higher contributions from GP clinic and specialist care services.

• Net profit rose sharply to S$1.10 million (from S$0.35 million in FY2024), reflecting a turnaround and improved operational performance across all divisions.

• EBITDA for the year climbed 34% to S$6.74 million, highlighting enhanced cost management and scale benefits.

• Cash and cash equivalents stood at S$16.4 million as of 30 June 2025; group net asset value per share increased to 11.8 cents.

• Growth momentum supported by winning new large contracts including a significant Health Promotion Board project for clinic management systems.

• Dividend payout: S$206,390 (1 cent per share) was declared and paid for FY2025.

• No impairment of goodwill needed during the year; all segments showed resilience, and new clinics and services contributed to market expansion.

• Strategic focus remains on expanding managed care programs, digital and telemedicine offerings, and specialised medical services to capture new market opportunities in Singapore and the region.